Rose Rock Midstream (RRMS) Getting Somewhat Negative News Coverage, Report Finds

Media coverage about Rose Rock Midstream (NYSE:RRMS) has trended somewhat negative on Friday, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rose Rock Midstream earned a news sentiment score of -0.02 on Accern’s scale. Accern also assigned news stories about the oil and gas company an impact score of 46.1826584712132 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2017/11/03/rose-rock-midstream-rrms-getting-somewhat-negative-news-coverage-report-finds.html.

About Rose Rock Midstream

Rose Rock Midstream, L.P. owns, operates, develops and acquires diversified portfolio of midstream energy assets. The Company is engaged in providing midstream energy related services, such as crude oil gathering, transportation, storage, distribution and marketing in Colorado, Kansas, Minnesota, Montana, North Dakota, Ohio, Oklahoma, Pennsylvania, Texas and Wyoming.

Insider Buying and Selling by Quarter for Rose Rock Midstream (NYSE:RRMS)

What are top analysts saying about Rose Rock Midstream LP? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Rose Rock Midstream LP and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit